Sensitive measurements of cellular Zn(II) uptake currently rely on quantitating radioactive emissions from cells treated with 65 Zn(II). Here, we describe a straightforward and reliable method employing a stable isotope to sensitively measure Zn(II) uptake by metazoan cells. First, biological medium selectively depleted of natural abundance Zn(II) using A12-resin [Richardson, C. E. R., et al.
Z n(II) mediates inter-and intracellular signaling 1−4 and is an obligatory cofactor for members of nearly all enzyme classes. 5, 6 Loosely bound or "mobile" pools of zinc modulate neurotransmission, 3, 7, 8 particularly in the context of sensory perception, 1, 3 and Zn(II) fluxes play important roles in diverse biological settings, including immune responses, 9 fertilization, 10, 11 and mammary tissue function. 12, 13 Establishing mechanisms of Zn(II) function in these and other processes benefits from methods for assaying cellular Zn(II) uptake and trafficking.
Small molecule sensors and genetically encoded sensors that exhibit a fluorescent signal upon Zn(II) binding are valuable tools for studying the roles of Zn(II) in tissues and cells. 14−18 These sensors, however, are designed to detect mobile Zn(II), which is a labile pool of Zn(II) that comprises only a small fraction of the total Zn(II) in most cell types. 14 Consequently, they are not generally useful for quantifying Zn(II) uptake or measuring changes in total cellular Zn(II).
Instead, investigators typically measure cellular assimilation of the radioisotope 65 Zn(II), a gamma emitter (t 1/2 = 244 days) that can be spiked into cell culture medium or a defined medium or administered to a live animal. 19−21 Despite the high sensitivity afforded by the use of a radioactive isotope, broad application of 65 Zn(II) to monitor Zn(II) uptake is hampered by practical concerns associated with a gamma-emitting radioisotope, including requirements for specialized protective equipment. Furthermore, measurement of 65 Zn(II) uptake cannot report on total cellular Zn(II), an important parameter that must then be evaluated in a parallel assay. In contrast, inductively coupled plasma-mass spectrometry (ICP-MS) permits sensitive measurement of the total cellular metal content, but routine ICP-MS experiments provide only the total metal per unit of cellular material and often cannot readily define Zn(II)-uptake rates.
A protocol combining the advantages of both methods, the high signal-to-noise ratio afforded by radioactivity-based assays and the experimental simplicity and capacity to quantitate total Zn(II) provided by ICP-MS, would be valuable. The natural abundance of the 70 Zn(II) isotope is 0.62%, but it can be sourced at high enrichment (≤72%) and is readily quantitated using ICP-MS. 22−26 Thus, one approach previously applied in whole animal studies and bacterial/yeast experiments is to employ a highly 70 Zn(II)-enriched diet or chemically defined microbial growth medium followed by ICP-MS to quantitate 70 Zn(II) during uptake or excretion studies. 22−26 A similar approach to measure Zn(II) uptake could, in principle, be taken in mammalian cell culture. One option is to spike tissue culture medium containing the natural abundance Zn(II) isotope distribution with 70 Zn(II). 27 Unfortunately, this strategy suffers from low sensitivity at early time points unless a large quantity of 70 Zn(II) is added to the medium, elevating total medium Zn(II) concentrations to levels that far exceed those in unmodified media. An alternative option would be to deplete the cell culture medium of Zn(II) and then add 70 Zn(II) back at high enrichment.
We recently developed the "A12-resin", comprising the Zn(II)-binding S100A12 protein immobilized on an agarose support. 28 A12-resin selectively removes Zn(II) from diverse and complex biological media without perturbing concentrations of other metal ions. 29 We anticipated that, by treating tissue culture media with A12-resin to remove natural abundance Zn(II), followed by repletion with 70 Zn(II), we could enrich 70 Zn(II) by >100-fold over its natural abundance in normal media. To measure the kinetics of 70 Zn(II) uptake, cells could then be "pulsed" with this 70 Zn(II)-enriched medium and the intracellular accumulation of the isotope could be measured by ICP-MS as a function of time ( Figure  1 ). Such a protocol would enable ICP-MS-based measurements of Zn(II) uptake by cells cultured in media containing typical Zn(II) concentrations (Figure 1 ), unlike the 70 Zn(II) "spike-in" approach mentioned above. 27 On the basis of the foregoing premise, we developed and optimized an assay for quantitation of Zn(II) uptake by metazoan cells. To demonstrate the utility of the method, we (i) measured 70 Zn(II)-uptake kinetics in several cell lines, (ii) assessed the enhancement or attenuation of Zn(II) uptake by a variety of chemical or genetic perturbations, and (iii) investigated whether cell state and lineage alter the selectivity for Zn(II) versus Cd(II) uptake. The results are reported here.
■ MATERIALS AND METHODS
Preparation of Media, Cell Lines, and Reagents. HEK293T, HeLa, HepG2, and HT1080 cells (maintained at fewer than 30 passages) were grown in complete Dulbecco's modified Eagle's medium (DMEM, Corning) supplemented with 10% fetal bovine serum (FBS), 100 IU penicillin, 100 μg/ mL streptomycin, and 2 mM L-glutamine in a humidified, 37°C incubator maintained at 5% CO 2 (g). DMEM with 10% FBS (DMEM/FBS) was depleted of Zn(II) with A12-resin prepared and applied as previously described. 28 70 Zn(II)gluconate was purchased from Millipore Sigma as a solid. To prepare 70 Zn(II)-enriched media, 70 Zn(II)-gluconate (1.0 mg/ mL in Milli-Q water) was titrated into Zn(II)-depleted DMEM/FBS and ICP-MS-measured concentrations of 64 Zn, 66 Zn, 67 Zn, 69 Zn, and 70 Zn were summed until the total Zn concentration in the medium was approximately 250 ppb (∼3.8 μM) total Zn(II). Sources of all other reagents are provided in the Supporting Information.
Zn(II)-Uptake Assay. HEK293T cells (∼500000) were plated in a six-well dish. After 2 days, the medium was aspirated and 70 Zn(II)-enriched medium (1.0 mL) was added to each appropriate well. Cells were harvested by first washing each well with phosphate-buffered saline (PBS) containing EDTA (100 μM, 2 × 2.0 mL) and subsequently adding Milli-Q water (18.2 MΩ cm, 1.00 mL) to each well and incubating for 2−4 min. A portion of the resulting cell lysate (0.90 mL) was collected and transferred to an Eppendorf Safe-Lock tube, snap-frozen in N 2 (l), and then thawed at room temperature (rt) for a total of three freeze−thaw cycles. The insoluble lysate was pelleted (10 min at 10000g), and the soluble protein concentration of each sample was determined by using the Pierce 660 nm Protein Assay in a 96-well plate (200 μL of reagent, 14 μL of sample, bovine serum albumin standard curve). Samples were then frozen and lyophilized overnight, and the resulting white, flaky solid was taken up in concentrated nitric acid (0.20 mL, ultrapure for trace metal analysis, BDH Aristar) and heated at 70°C for 1 h. A portion of each sample (142 μL) was then diluted with water (2.00 mL) and a Tb internal standard (Agilent 5190-8590, stock at 10000 ppb in 10% nitric acid diluted to 100 ppb in Milli-Q water for addition to samples, 2 ppb final concentration), after which the metal content of the samples was assessed by ICP-MS. Time points on the abscissa of plots and described in the text refer to the harvesting times following administration of the 70 Zn(II) pulse. The time point 0 h refers to a population of cells harvested immediately after addition of 70 Zn(II)-enriched media to parallel samples but never treated with such media.
Metal Competition Assay. For metal competition experiments, the Zn(II)-uptake assay protocol described above was followed, with the modification that 50 μM Cd(II)(aq), Co(II)(aq), Cu(II)(aq), Fe(II)(aq), Mn(II)(aq), Ni(II)(aq), or Zn(II)(aq) (natural abundance isotope distribution) was added from a 20 mM stock solution, as indicated, to 70 Zn(II)-enriched media prior to cell treatment. The solution of the Fe(II)(aq) solution was prepared by reduction of Fe(III) in 0.1 N HCl with ascorbate (10 equiv) immediately prior to addition to DMEM/FBS. ICP-MS. The concentrations of Mg, Ca, Fe, Mn, Co, Ni, Zn isotopes, and Cd were measured by using an Agilent 7900 ICP-MS instrument equipped with an integrated autosampler, in helium mode at the MIT CEHS Bioimaging and Chemical Analysis Core Facility, as previously reported. 30 Nitric acid used for ICP-MS sample and standard preparation was ultrapure for trace metals analysis grade (BDH Aristar). Samples for cell pellet ICP-MS were prepared as described above. The ICP-MS instrument was calibrated with dilutions of the Agilent Environmental Calibration Standard Mix (Mg, Ca, Fe: 0−500000 ppb; Mn, Co, Ni, Zn: 0−5000 ppb) at 5% nitric acid for cell pellet ICP-MS and at 1.5% nitric acid for cell culture medium ICP-MS. Solutions of DMEM/FBS were prepared for ICP-MS measurement by 1:2 dilution of the medium with 3% nitric acid (prepared by addition of 22 parts water to 1 part 70% nitric acid) followed by addition of the Tb internal standard to 2 ppb (Agilent, described above). 
Biochemistry
From the Bench A modification of this protocol was used to measure the 70 Zn content of 70 Zn(II)-enriched DMEM/FBS. The natural abundance of 70 Zn is 0.62%. The commercially available calibration standard used to calibrate the ICP-MS has, at the highest concentration used, 31 ppb 70 Zn. Therefore, 70 Zn(II)enriched medium was diluted 1:10 in ultrapure water and then further diluted 1:2 with 3% nitric acid before addition of a 2 ppb Tb internal standard (Agilent, described above) prior to ICP-MS analysis.
To calculate the molarities, and the corresponding molar amounts, of metals in samples, a density of 1.00 g/mL was assumed for all solutions. Therefore, 1.00 ppb was taken to be equal to 1.00 μg/L, and the molarity of a particular solution equal to the measured concentration of a particular ion in parts per billion, divided by the molecular weight of the ion, multiplied by 10 −6 .
Cloning and Expression of ZIP4, ZIP8, and ZIP10 into CMV-Sport 6. Primers for amplifying the coding sequence of each gene from pEntr233 31 and installing an N-terminal KpnI cut site and a C-terminal stop codon and XhoI site (for ZIP8 and ZIP10) or XbaI site (ZIP4) were designed and ordered from Sigma (Table S1 ). The genes were amplified via polymerase chain reaction (PCR) by using Q5 polymerase (NEB), and each PCR product was gel-purified. A vector encoding alkaline phosphatase (GE Dharmacon 5754297) in the CMV-Sport 6 backbone was digested in parallel with the PCR products mentioned above using the appropriate restriction enzymes, as indicated. Inserts were ligated into the CMV-Sport 6 backbone using T4 ligase (NEB) before transformation into chemically competent DH10B Escherichia coli. Mini-prepped plasmids were sequence-confirmed. Vectors were midi-prepped using an Omega E.Z.N.A. Plasmid Midi Kit. Immediately before transfection, plasmid DNA was further purified with a Cycle Pure Kit (Omega). Subsequently, HEK293T cells plated at a density of 5 × 10 6 cells per 10 cm dish the previous day were transfected using Lipofectamine 3000 at half the manufacturer-recommended reagent volumes and DNA mass. The following day, transfected cells were plated and treated as described in the Zn(II)-uptake assay protocol. Expression of transfected cDNA constructs was assessed by using quantitative PCR on samples parallel to those harvested for metal analysis.
Quantitative PCR (qPCR). Cells were washed with PBS, and RNA was extracted using the Omega E.Z.N.A. Total RNA Extraction Kit. cDNA was prepared from 1.00 μg of RNA with an Applied Biosystems Reverse Transcriptase cDNA Kit in a thermocycler. Samples were analyzed in a Light Cycler 480 II Real Time PCR Instrument in the MIT BioMicro Center following previously described methods. 32 qPCR primer specificity was assessed by agarose gel electrophoresis and melting curve analyses. Primer sequences are listed in Table  S1 .
Statistical Analyses. For each experiment, either individual biological replicates are shown along with the mean and standard error of the mean (SEM) or solid bars indicating the magnitude of the mean are shown with error bars showing the standard error of the mean (SEM). Statistical significance was assessed by using an unpaired heteroskedastic Student's t test in Microsoft Excel. Where appropriate, p values were adjusted with the Bonferroni correction. 33 ■ RESULTS AND DISCUSSION Zn(II)-Uptake Assay Development and Validation. We began by preparing 70 Zn(II)-enriched culture medium by replenishing A12-resin-depleted tissue culture media 28 with 70 Zn(II)-enriched zinc gluconate ( Figure 1 ). This protocol afforded DMEM/FBS that contained approximately 70% 70 Zn(II) (Table S2 ), a >100-fold enrichment of 70 Zn relative to the isotope's natural abundance of 0.62% at a normal (∼3.8 μM) concentration of Zn.
Next, we used this 70 Zn(II)-enriched medium to assay cellular Zn(II) uptake under conditions of normal cell proliferation via the following protocol. (1) Two days after cells had been plated in six-well dishes in complete DMEM/ FBS, the medium was replaced with 70 Zn(II)-enriched medium. (2) Cells were incubated at 37°C and then harvested 15, 30, 60, or 120 min after the medium had been changed. At each time point, cell monolayers were washed with 100 μM EDTA in PBS before being taken up in water (18.2 MΩ cm) directly in the plate. (3) After each cell lysate had been transferred to a microcentrifuge tube and frozen and thawed, the protein concentration was determined. (4) Samples were then snap-frozen in liquid nitrogen and lyophilized overnight. 
From the Bench this assay, the measurable consequence of such 70 Zn(II) secretion would probably be nonlinear cellular accumulation of 70 Zn(II). Therefore, the observation of linear uptake ( Figure  2b) is consistent with Zn(II) excretion not confounding the results of the assay over this 2 h time course.
Notably, the assay was sufficiently sensitive to measure uptake of 120 pmol of 70 Zn per milligram of protein after incubation in 70 Zn(II)-enriched medium for 15 min. Previously, to the best of our knowledge, only 65 Zn radioactivity-based assays could be applied to measure such small changes in Zn(II) uptake by human cells. We also note that the 70 Zn-uptake velocity measured in these experiments 6 pmol per milligram of protein per min was consistent with rates derived from assessing 65 Zn(II) uptake in HEK293T cells, which are reported to vary from 2 to 50 pmol per milligram of protein per min at an extracellular Zn(II) concentration of approximately 4 μM. 34−37 This wide range highlights the critical role of the detailed protocol used in a given Zn(II)-uptake assay. For instance, detergent-mediated lysis can solubilize 5-fold more protein than freeze−thaw cycles in detergent-free buffer, 38 the protocol used here. Thus, reported uptake parameters normalized to total protein using different lysis techniques should be expected to differ by as much as a factor of 5. Other protocol-specific factors can further broaden the range of measured uptake parameters. As a consequence of such considerations, uptake rate comparisons are best made between experiments conducted with identical protocols.
A key advantage of our protocol over approaches in which 70 Zn(II) is "spiked" into media is that it affords high sensitivity. We found that it is possible to measure uptake of 70 Zn over the course of 5 h if DMEM/FBS is spiked with 20 ppb 70 Zn(II), similar to prior ICP-MS-based protocols ( Figure S1 ). 27 However, when we used 70 Zn(II)-enriched medium prepared by using the A12-resin as described above, we observed a >10fold increase in sensitivity compared to that measured upon spiking DMEM/FBS with 20 ppb 70 Zn(II) ( Figure S1 ). We next used two separate experimental approaches to assess whether this ICP-MS-based Zn(II)-uptake assay selectively measures intracellular Zn(II), as opposed to Zn(II) adhering to cell surfaces or to tissue culture plasticware. Previous work with 65 Zn revealed that the rate of Zn(II) uptake is significantly diminished at low temperatures, 39 consistent with the lower activity of recombinant ZIP-family Zn(II) transporters at such temperatures. 40 Therefore, in our first approach, we maintained cell monolayers at either 4 or 37°C throughout a 2 h pulse with 70 Zn(II)-enriched medium (Figure 3a ). Across three cell lines, we observed much more 70 Zn(II) uptake in cells maintained at 37°C than in those maintained at 4°C (Figure 3b ). In a second experiment, after exposing cells to a 2 h pulse of 70 Zn(II)-enriched medium, we washed the cell monolayers with PBS containing one of three metal chelators at 100 μM each of which is known to bind Zn(II) with different affinities and with different associated rate constants ( Figure S2a −c), 7 or with PBS lacking a chelator. Cells were then harvested and prepared for ICP-MS analysis following our standard protocol. None of the chelators altered the subsequent measured amount of 70 Zn(II) levels in cell lysates ( Figure S2d ). Together, these results are consistent with the conclusion that this 70 Zn-uptake assay measures intracellular 70 Zn(II) levels, not 70 Zn(II) bound to cell surfaces or plates.
Confident that this assay measures Zn(II) taken up by cells, we next assessed whether it could be used to evaluate the effect of perturbations on Zn(II) uptake mediated by either the metal chelator N,N,N′,N′-tetrakis(2-pyridinylmethyl)-1,2-ethanediamine (TPEN) or the ionophore pyrithione. Briefly, HEK293T cells were incubated with 70 Zn(II)-enriched medium [3.8 μM total Zn(II)] containing either TPEN [5 μM, forms a 1:1 complex with Zn(II)] or pyrithione [10 μM, forms a 1:2 complex with Zn(II) (Figure 4a−c) ]. TPEN significantly diminished the rate of cellular Zn(II) uptake (Figure 4d ), suggesting that cells are unable to effectively take up Zn(II)-bound TPEN. In contrast, and as expected on the basis of prior work in which pyrithione was used to deliver Zn(II) into cells, 41, 42 this ionophore significantly increased the 70 Zn(II) content of HEK293T cells (Figure 4e ). Pyrithione treatment also enhanced total Zn(II) per milligram of protein relative to that of cells not treated with pyrithione (Figure 4f ), indicating that pyrithione enhances the rate of Zn(II) uptake more than the rate of Zn(II) efflux.
One key advantage of an ICP-MS assay for Zn(II) uptake over a radioactivity-based assay is that the concentrations of other metals can be measured simultaneously with that of Zn. By analyzing levels of other metal ions, we found that pyrithione treatment did not increase total cellular Mn or Fe levels but, consistent with previous reports, 41 it did significantly increase the cellular concentration of Cu (Figure 4g−i; note that the concentration of Cu in DMEM/FBS is approximately 200 nM). This observation highlights that experiments in which cells are treated with high concentrations of Zn(II)-pyrithione should be interpreted with caution, as the reagent can significantly perturb cellular Cu levels.
Collectively, these experiments show that depletion of natural abundance Zn(II) from tissue culture media using the A12-resin followed by repletion with 70 Zn(II) yields an assay for Zn(II) uptake by metazoan cells that is sensitive and straightforward to apply. Moreover, while we have performed the assay at normal Zn(II) concentrations (∼3.8 μM), 28 we note that it could be performed at a range of 70 Zn(II) concentrations by repleting 70 Zn(II) to different final concentrations, providing additional experimental flexibility. In the following sections, we illustrate the utility of this assay Monitoring How Genetic Perturbations Modulate Zn(II)-Uptake Kinetics. We next employed our 70 Zn(II)uptake assay to examine the effects of Zn(II) transporter overexpression on Zn(II) uptake, an experiment that has previously been performed only with the radioactivity-based 65 Zn(II) assay, to the best of our knowledge. 21 We selected three cell-surface-localized Zn(II) transporters thought to deliver Zn(II) from outside the cell into the cytosol, specifically ZIP4, ZIP8, and ZIP10. Two factors motivated selection of these particular transporters. 43 First, uptake through ZIP transporters is one of the main routes by which Zn(II) enters metazoan cells. 43 Second, previous work established both ZIP4 and ZIP8 as bona fide Zn(II) transporters. 35, 44, 45 On the other hand, although ZIP10 is known to be transcriptionally upregulated under Zn(II)deficient conditions, 46 to the best of our knowledge the potential impact of human ZIP10 expression on Zn(II) uptake has not been rigorously evaluated to date.
We began by transfecting vectors encoding either SLC39A4/ ZIP4, SLC39A8/ZIP8, SLC39A10/ZIP10, or GFP (as a control) into HEK293T cells. qPCR analysis revealed that ZIP4, ZIP8, and ZIP10 mRNA levels were all enhanced as a consequence of the transfection ( Figure S3 ). Further corroborating successful overexpression of two of the ZIP transporters, levels of transcripts encoding metallothionein 1A, a transcriptionally regulated Zn(II)-buffering protein in mammalian cells, 5 were significantly enhanced in cells overexpressing ZIP4 and ZIP8 ( Figure S3 ). Elevated metallothionein transcript levels are consistent with elevated intracellular Zn(II) content. 47 Transfected HEK293T cells were next incubated in 70 Zn-(II)-enriched media for 2 h before ICP-MS analysis of 70 Zn(II) content, revealing two key results (Figure 5a ). First, across experiments, significantly (p < 0.001) more 70 Zn accumulated in cells overexpressing any one of the three ZIP transporters during the pulse than in GFP-expressing cells (Figure 5b ). This observation is in agreement with previous reports showing that both ZIP4 and ZIP8 expression enhance the rate of Zn(II) uptake 35, 45 and supports the notion that ZIP10, like other human ZIP-family members, transports Zn(II). Second, and consistent with literature reports regarding other ZIPs, 21 ZIP overexpression significantly increased (p < 0.01) total Zn(II) per milligram of protein relative to cells expressing GFP (Figure 5c ). Both observations, an increased Zn(II)-uptake rate and increased total Zn(II) upon ZIP overexpression, are important to consider given that aberrant ZIP expression is associated with a number of human pathologies. 48, 49 In summary, monitoring 70 Zn(II) uptake from 70 Zn(II)enriched media provides an alternative to measuring radioactive 65 Zn(II) uptake that can be used to sensitively evaluate HEK293T cells transfected with ZIP4, ZIP8, or ZIP10 contained significantly more total Zn(II) than did cells expressing GFP (N = 3; ±SEM). p values are from a Student's t test adjusted with the Bonferroni correction for multiple testing (***p < 0.001; **p < 0.01).
From the Bench how genetic perturbations impact Zn(II) uptake. Application of the assay here provided evidence that ZIP10 is a Zn(II) transporter. We anticipate that, beyond cell-surface Zn(II) transporters, this experimental procedure could be used to assess the effects of diverse genetic and chemical genetic perturbations on cellular Zn(II) uptake. Candidate proteins for future work could include those involved in Zn(II) homeostasis [e.g., metallothioneins and intracellular Zn(II) transporters] or zinc-binding proteins (e.g., zinc-finger transcription factors or zinc enzymes).
Metal Competition Experiments. As noted above, one benefit of using ICP-MS to monitor 70 Zn(II) uptake is that a single experiment reports on Zn(II)-uptake kinetics, total cellular Zn(II) content, and changes in the levels of other metals. With regard to this last point, the ability to monitor multiple metals in a single experiment can be important in many contexts. For instance, this capability is valuable when assessing selectivity of metal uptake. In a typical radioactivitybased experiment to assess uptake selectivity using 65 Zn(II), a decrease in 65 Zn(II) uptake is commonly taken to indicate competition by other metals for uptake through Zn(II) transporters. 21, 34, 35, 39, 50, 51 However, unless the uptake of other ions is directly measured, possibly by using a second radioisotope, 45, 52, 53 such a conclusion is necessarily uncertain.
To investigate whether other metals compete with Zn(II) for uptake by HEK293T cells, we prepared 70 Zn(II)-repleted DMEM/FBS alone or with a 50 μM [∼13 equiv relative to Zn(II) levels in 70 Zn(II)-repleted DMEM/FBS] supplement of another metal ion [Cd(II), Co(II), Cu(II), Fe(II), Mn(II), Ni(II), and natural abundance Zn(II)]. We then monitored (i) the effect of other metal ions on 70 Zn(II) uptake over a 2 h 70 Zn(II) pulse with this medium (Figure 6a ) and (ii) the intracellular accumulation of each ion (Figure 6c −g, Figure  S4 ).
Consistent with literature reports, 21, 34, 35, 39, 50, 51 each metal ion significantly (p < 0.001) attenuated 70 Zn(II) uptake, with the greatest diminution of uptake caused by Cd(II) ( Figure  6b ). Inhibition of Zn(II) uptake by Cd(II) may be explained by the fact that the closed-shell d 10 metal ions Cd(II) and Zn(II) often bind at the same sites in proteins and have similar binding affinities for amino acid residues. 54, 55 Thus, it is likely that a principal mechanism by which the toxic metal Cd(II) enters cells involves co-opting endogenous Zn(II)-uptake machinery. The inhibition of Zn(II) uptake by Cd(II) taken together with the cellular accumulation of the latter ( Figure   6c ) is consistent with this hypothesis. Coordinated uptake inhibition and accumulation were not observed for the other metal ions (Figure 6b ,d−g). For instance, Mn(II) lowers Zn(II) uptake to a lesser extent than does Cd(II), but Mn(II) nonetheless markedly accumulates in HEK293T cells. Taken together, these observations suggest that Mn(II) uptake in this context is not mediated by Zn(II) transport machinery. Overall, monitoring total cellular metal ion levels in these experiments can provide important mechanistic information regarding metal uptake.
The molecular basis for the selectivity of Zn uptake versus Mn, Fe, Co, and Ni uptake is unclear. Selection for Zn over Fe, Mn, and Co may be rationalized on the basis of the Irving− Williams series, 56 which describes the binding preferences of ligands for first-row transition metals in octahedral ligand fields and is related to decreasing ionic radii across the series. For instance, Zn(II) binds ∼10 4 -fold more tightly to zinc-finger mimics than does Co(II), 57 an ion often used as a proxy for Zn(II) in protein biochemistry. 58 However, justification of selection against Cu(II) is challenging because the series predicts greater affinity of ligands for Cu(II) than for Zn(II). We expect that future structural studies of Zn(II) transporters in tandem with assays like the one we report here may allow prediction or explication of Zn(II) transporter selectivity.
Zn(II) Deficiency Alters the Metal Ion Selectivity of Cellular Zn(II)-Uptake Systems. The observation that Cd(II) strongly inhibits Zn(II) uptake (Figure 6b ) motivated us to probe how Zn(II) deficiency affects relative Zn(II)-and Cd(II)-uptake rates. We were inspired by a recent approach using a trace amount of 70 Zn(II) in which Cd-and 70 Zn-uptake rates were directly compared. 59 The protocol we describe below, however, utilizes a medium with a greater enrichment of 70 Zn and therefore has the potential to afford superior signal and resolution over a shorter experimental time window.
In particular, we sought to evaluate how cellular metaluptake selectivity for Cd(II) over Zn(II) is affected by (i) Zn(II) deficiency or (ii) cell lineage. The former is a question of singular interest because Zn(II) deficiency alters zinc importer expression patterns. 46 The latter question arises because different cell types express different zinc transporters and different zinc transporters exhibit different metal selectivities. 60 Because the cellular concentrations of both Cd(II) and 70 Zn(II) are very low in cells grown in DMEM/ FBS, we could readily calculate the selectivity of cellular metaluptake machinery defined as S Zn,Cd using eq 1: (1) Note that this calculation is specifically made possible by the use of 70 Zn(II)-enriched media in these assays. A key benefit of computing the ratio of 70 Zn to Cd is that normalization of measured metal content to protein concentration is unnecessary, reducing the number of experimental steps required for the assay.
We began by culturing HEK293T cells in either Zn(II)depleted or Zn(II)-adequate (medium was treated with a control resin 28 ) medium for 24 h (Figure 7a ). We then cultured the cells in 70 Zn(II)-enriched medium containing 5 μM Cd(II) for 2 h before analyzing cell metal content according to our usual protocol. HEK293T cells starved of Zn(II) exhibited an S Zn,Cd value ∼3-fold greater than that of cells cultured under Zn(II)-adequate conditions, indicating that Zn(II)-starved HEK293T cells preferentially take up Zn(II) over Cd(II) to a greater extent than cells cultured under Zn(II)-adequate conditions (Figure 7b ). Cell lines of diverse lineages, including HepG2, HeLa, and HT1080, exhibited this trend after growing for 48 h in Zn(II)-depleted or Zn(II)-adequate medium; however, the magnitude of S Zn,Cd was different for each cell line (Figure 7b ). For instance, HepG2 cells were markedly less selective for Zn(II) over Cd(II) than any other tested cell line. The identities of transporters that (i) underlie changes in uptake selectivity in the context of Zn(II) deficiency and (ii) account for differences in uptake selectivity of cell lines are presently unknown but merit further investigation.
■ SUMMARY AND CONCLUSIONS
In summary, we present the design, validation, and implementation of a protocol for measuring Zn(II) uptake by cultured metazoan cells. Depletion of cell culture medium of Zn(II) using the A12-resin, followed by repletion of the medium with 70 Zn(II), enables highly sensitive quantitation of cellular Zn(II) uptake from media containing normal Zn(II) concentrations. There are at least three advantages of this approach over other methods for monitoring Zn(II) uptake. First, the assay does not rely on a gamma-emitting radioisotope of Zn(II). Second, the assay is designed to measure Zn(II) uptake from cell culture media rather than abiological buffers commonly used in radioactivity assays. Third, because ICP-MS is used as the detection technique, the assay provides simultaneous insight into how total cellular Zn and other metal concentrations change as a consequence of any perturbation of interest.
We envision that the methods described herein will have many applications in the study of metazoan Zn(II) biology. In particular, we anticipate that the 70 Zn(II)-uptake assay will be well-suited for discovering small molecules that modulate Zn(II) transport and/or for single-cell ICP-MS experiments to assess heterogeneity in Zn(II)-uptake rates in cell populations. We also expect that organelles or proteins of interest could be purified after a 70 Zn(II) pulse and that the abundance of 70 Zn in the sample could be quantified to gain insights into cellular Zn(II) trafficking. Finally, our protocol could be modified to study either the secretion of Zn(II) metalloproteins or Zn(II) efflux by first "loading" cells with 70 Zn(II) prior to culture in media lacking 70 Zn and subsequently assessing 70 Zn(II) levels outside the cell.
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